Cargando…
DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
Ovarian cancer (OC) is the seventh most common type of cancer in women worldwide. Treatment for OC usually involves a combination of surgery and chemotherapy with carboplatin and paclitaxel. Platinum-based agents exert their cytotoxic action through development of DNA damage, including the formation...
Autores principales: | Stefanou, Dimitra T., Souliotis, Vassilis L., Zakopoulou, Roubini, Liontos, Michalis, Bamias, Aristotelis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773153/ https://www.ncbi.nlm.nih.gov/pubmed/35052761 http://dx.doi.org/10.3390/biomedicines10010082 |
Ejemplares similares
-
Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2015) -
Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
por: Stefanou, Dimitra T., et al.
Publicado: (2021) -
Oxidative Stress and Deregulated DNA Damage Response Network in Lung Cancer Patients
por: Stefanou, Dimitra T., et al.
Publicado: (2022) -
The Role of Circular RNAs in DNA Damage Response and Repair
por: Papaspyropoulos, Angelos, et al.
Publicado: (2021) -
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility
por: Rodolakis, Ioannis, et al.
Publicado: (2023)